Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... r />
The report provides comprehensive information on the therapeutics under development for Lafora Disease (Unverricht Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 30-Apr-2021 | $2000 | |
Pick Disease (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... apeutics under development for Pick Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the......" | 30-Apr-2021 | $2000 | |
Radiculopathy (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... herapeutics under development for Radiculopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of......" | 30-Apr-2021 | $2000 | |
Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... a) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Social Anxiety Disorder (SAD/Social Phobia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action ......" | 30-Apr-2021 | $2000 | |
Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Cognitive Impairment, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descripti......" | 30-Apr-2021 | $2000 | |
Drug-Induced Dyskinesia (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... rehensive information on the therapeutics under development for Drug-Induced Dyskinesia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers t......" | 30-Apr-2021 | $2000 | |
Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... sease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dementia Associated With Alzheimer's Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Act......" | 30-Apr-2021 | $2000 | |
Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 30-Apr-2021 | $2000 | |
Dystonia (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... er development for Dystonia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, i......" | 30-Apr-2021 | $2000 | |
Sleep Disorders (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Sleep Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological A......" | 30-Apr-2021 | $2000 | |
|